ADMA Biologics Inc
Company Profile
Business description
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Contact
465 State Route 17
RamseyNJ07446
USAT: +1 201 478-5552
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
685
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,467.00 | 4.40 | 0.05% |
| CAC 40 | 7,850.37 | 106.62 | 1.38% |
| DAX 40 | 23,540.17 | 40.85 | 0.17% |
| Dow JONES (US) | 42,219.22 | 969.84 | 2.35% |
| FTSE 100 | 8,606.53 | 51.73 | 0.60% |
| HKSE | 23,549.46 | 681.72 | 2.98% |
| NASDAQ | 18,556.40 | 627.48 | 3.50% |
| Nikkei 225 | 37,644.26 | 140.93 | 0.38% |
| NZX 50 Index | 12,676.75 | 71.68 | 0.57% |
| S&P 500 | 5,808.58 | 148.67 | 2.63% |
| S&P/ASX 200 | 8,233.50 | 2.30 | 0.03% |
| SSE Composite Index | 3,369.24 | 27.25 | 0.82% |